Effect of dobutamine on left ventricular functional geometry after acute myocardial infarction: Experimental study

Hellenic Journal of Cardiology

Volumn 48, Issue 2, 2007, Pages 72-79

  Saridakis, Nikolaos S ^a   Toumanidis, Savvas T ^a,b   Vintzileou, Anastasia M ^a   Tsirikos, Nikolaos ^a   Kottis, Georgios ^a   Kalantaridou, Anna ^a   Stamatelopoulos, Stamatios F ^a   Moulopoulos, Spyridon D ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

Acute myocardial infarction; Dobutamine; Echocardiography; Post infarction remodelling

Indexed keywords

DOBUTAMINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOTONIC AGENT;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; NONHUMAN; SWINE; ANALYSIS OF VARIANCE; ANIMAL; CORONARY BLOOD VESSEL; DISEASE MODEL; ECHOGRAPHY; HEART CONTRACTION; HEART INFARCTION; HEART STROKE VOLUME; IMAGE PROCESSING; INTRAVENOUS DRUG ADMINISTRATION; LIGATION; METHODOLOGY; PATHOPHYSIOLOGY; TIME; VASCULAR RESISTANCE;

ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CARDIOTONIC AGENTS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOBUTAMINE; ECHOCARDIOGRAPHY; IMAGE PROCESSING, COMPUTER-ASSISTED; INFUSIONS, INTRAVENOUS; LIGATION; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; RESEARCH DESIGN; STROKE VOLUME; SWINE; TIME FACTORS; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34548081483     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Omerovic E, Bollano E, Basetti M, et al: Bioenergetic, functional and morphological consequences of postinfarct cardiac remodeling in the rat. J Mol Cell Cardiol 1999; 31: 1685-1695.
2. Monassier JP, Morice MC, Hansen M, et al: Acute myocardial infarction: Recent physiopathological acquisitions. Part 2: Left ventricular function. Arch Mal Coeur Vaiss 1992; 85 Suppl: 671-676.
3. Anguenot T, Bassand JP, Bernard Y, et al: Left ventricular remodeling after myocardial infarction. Arch Mal Coeur Vaiss 1992; 85 Suppl. 781-787.
4. Bonaduce D, Petretta M, Bianchi V, et al: Left ventricular remodeling and function after myocardial infarction. Prim Cardiol 1993; 19: 41-48.
5. Krum Holz HM, Larson M, Levy D: Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol 1995; 25: 879 - 884.
6. Mckay RG, Pfeffer MA, Pasternak RC, et al: Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation 1986; 74: 693-702.
7. Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81: 1161-1172.
8. Anderson B, Waagstein F, Caidahi K, et al: Early changes in longitudinal performance predict future improvement in global left ventricular function during long term b-adrenergic blockade. Heart 2000; 84: 599-605.
9. Beckwith C, Munger MA, Maldonado WT, et al: Effect of angiotensin converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Ann Pharmacother 1993; 27: 755-756.
10. Nahrendorf M, Hu K, Hiller KH, et al: Impact of hydroxymethyl-glutaryl- coenzyme-A reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. J Am Coll Cardiol 2002; 40: 1965-2700.
11. Hauser A, Gangadharan V, Ramos R, et al: Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary occlusion in human beings: Echocardiographic observations during coronary angioplasty. J Am Coll Cardiol 1985; 5: 193-197.
12. Stamatelopoulos SF, Saridakis NS, Chatzis AK, et al: Nonsurgical infarctectomy in acute experimental myocardial infarction. Artificial Organs 1998; 22: 993- 997.
13. Shiller NB, Shah PM, Crawford M, et al: Recommendations for quantification of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-367.
14. Cazorla O, Szilagyi S, Le Guennec JV, et al: Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction. FASEB J 2005; 19: 88-90.
15. Stump GL, Wallage AA, Gilberto DB, et al: Arrhythmogenic potential of positive inotropic agents. Basic Res Cardiol 2000; 95: 186-198.
16. Miura T, Yoshida S, Miura O, et al: Dobutamine modifies myocardial infarct size through supply-demand balance. Am J Physiol 1988; 254: H855-861.
17. Liang CS, Yi JM, Sherman LG, et al: Dobutamine infusion in conscious dogs with and without acute myocardial infarction. Effects on systemic hemodynamics, myocardial blood flow, and infarct size. Circ Res 1981; 49: 170-180.
18. Takehana K, Ruiz M, Petruzella FD, et al: Response to incremental doses of dobutamine early after reperfusion is predictive of the degree of myocardial salvage in dogs with experimental acute myocardial infarction. J Am Coll Cardiol 2000; 35: 1960-1968.